RankingsPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Common stock and paid-in capital

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.05T
P/E ratio
22.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Mar 31, 2025568,083+0.21%
Mar 31, 2024566,894+0.49%
Mar 31, 2023564,104+0.32%
Mar 31, 2022562,291+0.29%
Mar 31, 2021560,654+0.06%
Mar 31, 2020560,330+0.04%
Mar 31, 2019560,125+0.01%
Mar 31, 2018560,043+100.14%
Mar 31, 2017279,823+0.00%
Mar 31, 2016279,823+0.00%
Mar 31, 2015279,823

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)